Serum urate association with hypertension in young adults: Analysis from the Coronary Artery Risk Development in Young Adults cohort

Annals of the Rheumatic Diseases

Volumn 72, Issue 8, 2013, Pages 1321-1327

  Gaffo, Angelo L ^a,b   Jacobs Jr , David R ^c,d   Sijtsma, Femke ^c   Lewis, Cora E ^e   Mikuls, Ted R ^f   Saag, Kenneth G ^b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; URATE;

ADULT; AFRICAN AMERICAN; ARTICLE; BIVARIATE ANALYSIS; CAUCASIAN; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; URIC ACID BLOOD LEVEL;

ARTERIAL HYPERTENSION; EPIDEMIOLOGY; HEALTH SERVICES RESEARCH;

COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; URIC ACID; YOUNG ADULT;

EID: 84880232785     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201916     Document Type: Article

References (41)

1. Grayson PC, Kim SY, Lavalley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:102-10.
2. Dyer AR, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary artery risk development in (young) adults. J Hum Hypertens 1999;13:13-21. (Pubitemid 29042140)
3. Hunt SC, Stephenson SH, Hopkins PN, et al. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991;17 (6 Pt 2):969-76.
4. Jossa F, Farinaro E, Panico S, et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994;8:677-81. (Pubitemid 24276965)
5. Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303. (Pubitemid 46143005)
6. Mellen PB, Bleyer AJ, Erlinger TP, et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006;48:1037-42. (Pubitemid 44772705)
7. Nagahama K, Inoue T, Iseki K, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004;27:835-41. (Pubitemid 40309449)
8. Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-30. (Pubitemid 36899556)
9. Panoulas VF, Douglas KM, Milionis HJ, et al. Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis. J Hum Hypertens 2008;22:177-82. (Pubitemid 351266485)
10. Perlstein TS, Gumieniak O, Williams GH, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006;48:1031-6. (Pubitemid 44772704)
11. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990;131:1017-27. (Pubitemid 20178623)
12. Sanchez-Lozada LG, Tapia E, Bautista-Garcia P, et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2008;294:F710-18.
13. Sanchez-Lozada LG, Tapia E, Soto V, et al. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia. Nephron Physiol 2008;108:p69-78. (Pubitemid 351704308)
14. Sanchez-Lozada LG, Tapia E, Soto V, et al. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia. Nephrol Dial Transplant 2008;23:1179-85. (Pubitemid 351767502)
15. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007;18:287-92. (Pubitemid 46053441)
16. Lu Z, Dong B, Wu H, et al. Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 2009;23:113-21.
17. Sundstrom J, Sullivan L, D'Agostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005;45:28-33. (Pubitemid 40066409)
18. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-7. (Pubitemid 34654464)
19. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008;300:924-32.
20. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972;15:189-92.
21. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16. (Pubitemid 19039041)
22. Cutter GR, Burke GL, Dyer AR, et al. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 1991;12(1 Suppl):1S-77S.
23. Stamp L, Ha L, Searle M, et al. Gout in renal transplant recipients. Nephrology (Carlton) 2006;11:367-71. (Pubitemid 44086883)
24. Adamopoulos D, Vlassopoulos C, Seitanides B, et al. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 1977;85:198-208. (Pubitemid 8087786)
25. Nicholls A, Snaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973;1:449-51.
26. Hozawa A, Jacobs DR Jr, Steffes MW, et al. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem 2007;53:447-55. (Pubitemid 46447941)
27. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
28. Jacobs DR Jr, Murtaugh MA, Steffes M, et al. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 2002;155:1114-19. (Pubitemid 34625500)
29. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. (Pubitemid 46768608)
30. Sidney S, Jacobs DR Jr, Haskell WL, et al. Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 1991;133:1231-45.
31. Imazu M, Yamamoto H, Toyofuku M, et al. Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001;24:531-6. (Pubitemid 33048919)
32. Shankar A, Klein R, Klein BE, et al. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006;20:937-45. (Pubitemid 44782827)
33. Taniguchi Y, Hayashi T, Tsumura K, et al. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001;19:1209-15. (Pubitemid 32595276)
34. Izzard AS, Rizzoni D, Agabiti-Rosei E, et al. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005;23:247-50. (Pubitemid 40279623)
35. Prewitt RL, Rice DC, Dobrian AD. Adaptation of resistance arteries to increases in pressure. Microcirculation 2002;9:295-304. (Pubitemid 135685864)
36. Kosugi T, Nakagawa T, Kamath D, et al. Uric acid and hypertension: an age-related relationship? J Hum Hypertens 2009;23:75-6.
37. Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83, 683 Austrian men. Clin Chem 2008;54:273-84. (Pubitemid 351302628)
38. Strasak AM, Kelleher CC, Brant LJ, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28, 613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008;125:232-9.
39. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42. (Pubitemid 40577708)
40. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005;52:283-9. (Pubitemid 40129260)
41. Gaffo AL, Roseman JM, Jacobs DR, et al. Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis 2010;69:1965-70.